Pramodini Medicare IPO

Pramodini Medicare Limited is a listed issue, offered in a price band of ₹118 to ₹118 per share, in lots of 2400 shares. Every figure below is taken from the issue's own filings and exchange disclosures.

Issue details

Price band

₹118 – ₹118

Lot size

2400 shares

Minimum investment

₹2,83,200

Issue size

₹69.04 Cr

Fresh issue

₹63.14 Cr

Offer for sale

₹5.9 Cr

Opens

12 Aug 2026

Closes

14 Aug 2026

Listing date

19 Aug 2026

Registrar

Pvt. Ltd.

Symbol

PRAMODINI

One lot of 2400 shares at the upper band price of ₹118 is ₹2,83,200 — the smallest retail application this issue accepts.

Lead managers: Smart Horizon Capital Advisors Pvt.Ltd.

Subscription status

How many times the issue has been applied for, by investor category, as reported by the exchange at 14 Aug 2026, 07:05 pm IST.

Grey market premium (GMP)

Latest reported GMP

₹0

Implied over upper band

0.00%

As of

17 Aug 2026, 07:05 pm IST

How the reported premium has moved. The trend matters more than any single reading — a premium that is drifting down into the close is a different signal from one holding firm.

Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.

Reported financials

As disclosed in the offer document. Figures in ₹ crore unless the filing states otherwise.

Strengths disclosed in the offer document

• The company has established a strategic presence across various states in India.
• The company has strengthened its network with diversified models.
• The company possesses technical capability with robust IT infrastructure.
• The company has a dedicated management team with significant industry experience.
• The company has a track record of revenue and financial performance.
• The company has a diverse customer base.
• The company focuses on a patient-centric approach to enhance quality of services and patient satisfaction.

Risk factors disclosed in the offer document

• A significant portion of revenue is derived from MOUs with government authorities under Public Private Partnership arrangements, and any non-renewal, modification, or termination of these MOUs may adversely affect the business.
• Concentrated emphasis on radiology services exposes the company to substantial risks that could adversely impact operations, financial performance, and long-term growth prospects.
• Substantial portion of revenue is derived from the state of Andhra Pradesh, and any loss of business in this region could have an adverse effect on the business.
• The company is majorly dependent on certain key customers cum patients for a substantial portion of its revenues, and loss of relationships with any of these customers may have a material adverse effect on profitability and results of operations.
• The company is required to obtain and maintain trade licenses for its operating premises, and any failure or delay in obtaining or renewing such licenses may adversely affect its business, operations and financial condition.
• The company is subject to extensive regulatory requirements governing its operations, and any failure to comply with such requirements may expose it to penalties and adversely affect its business, operations and financial condition.
• The company's registration records contain minor discrepancies in address details, and any delay in rectifying such discrepancies may require administrative actions and regulatory interactions.

These are the company's own disclosures, not Alphave's assessment. Read the offer document →

What this page will not tell you

Whether to apply

Alphave is NISM-certified, not a SEBI-registered research analyst. There is no rating, verdict or recommendation on this issue anywhere on this page.

What it will list at

Nobody knows, and GMP is not a forecast of it. It is an unofficial over-the-counter quote reported by third parties, shown here with its source time so you can judge how stale it is.

Your allotment

Allotment is decided by the registrar (Pvt. Ltd.) after the issue closes. Track the whole calendar in the IPO Centre.

← All current and upcoming IPOs · Open the interactive Pramodini Medicare terminal →